67 related articles for article (PubMed ID: 32728718)
1. Expression of Concern: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21.
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32728718
[No Abstract] [Full Text] [Related]
2. LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21.
Fei F; He Y; He S; He Z; Wang Y; Wu G; Li M
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30042166
[TBL] [Abstract][Full Text] [Related]
3. Retraction: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21.
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34647578
[No Abstract] [Full Text] [Related]
4. LncRNA-SNHG3 is an independent prognostic biomarker of intrahepatic cholangiocarcinoma.
Tian D; Wei X; Zhu H; Zhu L; Li T; Li W
Int J Clin Exp Pathol; 2019; 12(7):2706-2712. PubMed ID: 31934101
[TBL] [Abstract][Full Text] [Related]
5. LncRNA Snhg3 contributes to dysfunction of cerebral microvascular cells in intracerebral hemorrhage rats by activating the TWEAK/Fn14/STAT3 pathway.
Zhang J; Dong B; Hao J; Yi S; Cai W; Luo Z
Life Sci; 2019 Nov; 237():116929. PubMed ID: 31610210
[TBL] [Abstract][Full Text] [Related]
6. lncRNA SNHG3 acts as a novel Tumor Suppressor and regulates Tumor Proliferation and Metastasis via AKT/mTOR/ERK pathway in Papillary Thyroid Carcinoma.
Duan Y; Wang Z; Xu L; Sun L; Song H; Yin H; He F
J Cancer; 2020; 11(12):3492-3501. PubMed ID: 32284745
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis.
Wang L; Su K; Wu H; Li J; Song D
Life Sci; 2019 Sep; 232():116597. PubMed ID: 31238052
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma.
Zheng S; Jiang F; Ge D; Tang J; Chen H; Yang J; Yao Y; Yan J; Qiu J; Yin Z; Ni Y; Zhao L; Chen X; Li H; Yang L
Biomed Pharmacother; 2019 Apr; 112():108695. PubMed ID: 30797154
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma.
Chen J; Wu Z; Zhang Y
Int J Immunopathol Pharmacol; 2019; 33():2058738418820743. PubMed ID: 30791797
[TBL] [Abstract][Full Text] [Related]
11. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
Zhang T; Cao C; Wu D; Liu L
Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.
Ma Q; Qi X; Lin X; Li L; Chen L; Hu W
Hum Cell; 2020 Jan; 33(1):232-242. PubMed ID: 31586299
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
Huang W; Tian Y; Dong S; Cha Y; Li J; Guo X; Yuan X
Oncol Rep; 2017 Sep; 38(3):1402-1410. PubMed ID: 28731158
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma.
Zhang PF; Wang F; Wu J; Wu Y; Huang W; Liu D; Huang XY; Zhang XM; Ke AW
J Cell Physiol; 2019 Mar; 234(3):2788-2794. PubMed ID: 30132868
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA Snhg3 is essential for mouse embryonic stem cell self-renewal and pluripotency.
Lu W; Yu J; Shi F; Zhang J; Huang R; Yin S; Songyang Z; Huang J
Stem Cell Res Ther; 2019 May; 10(1):157. PubMed ID: 31151411
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Li N; Zhan X; Zhan X
Gynecol Oncol; 2018 Aug; 150(2):343-354. PubMed ID: 29921511
[TBL] [Abstract][Full Text] [Related]
18. The binding of lncRNA RP11-732M18.3 with 14-3-3 β/α accelerates p21 degradation and promotes glioma growth.
Kang CM; Bai HL; Li XH; Huang RY; Zhao JJ; Dai XY; Zheng L; Qiu YR; Hu YW; Wang Q
EBioMedicine; 2019 Jul; 45():58-69. PubMed ID: 31202814
[TBL] [Abstract][Full Text] [Related]
19. KLF2 induces the senescence of pancreatic cancer cells by cooperating with FOXO4 to upregulate p21.
Yuedi D; Houbao L; Pinxiang L; Hui W; Min T; Dexiang Z
Exp Cell Res; 2020 Mar; 388(1):111784. PubMed ID: 31866399
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
Yang JX; Liu B; Yang BY; Meng Q
Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
